OncoTAb
ORDER NOWSEEKING PHYSICIAN COLLABORATION
  • HOME
  • ABOUT
  • FAQ
  • SCIENCE & TECHNOLOGY
  • FIND A PHYSICIAN
  • NEWS
  • BLOG
  • HONOR WALL
  • CONTACT
  • PATIENT LOGIN
  • Shop0
  • lady with slide
    Concerned About Breast Cancer?
    OncoTAb's cutting edge patented technology was used to develop a blood test, Agkura™ Personal Score, which aids breast cancer detection in women with dense breast tissue.

Patient Portal

Login

Lost your password?

Your Cart

Get Your

Agkura™ Personal Score

Click Here
RSS Breast Cancer News
  • Does Preoperative Immunotherapy Improve Treatment of Locally Advanced Rectal Cancer?
    Immunotherapy May Improve Treatment of Rectal Cancer
  • Ipatasertib Precision Cancer Medicine for Prostate Cancer
    According to the results of a recent clinical study aggressive prostate cancers may be treated more effectively by combining an existing targeted medicine, Zytiga (abiraterone) with a new experimental drug to block two of cancer’s growth signals at once. The combination delayed prostate cancers ...
  • Could Genomic Testing Identify Breast Cancer Patients Who Can Avoid Adjuvant Radiotherapy?
    POLAR Genomic profile suggest some women with early stage breast cancer might avoid radiation therapy.
  • Tislelizumab in Esophageal Cancer
    Tislelizumab improved overall survival compared with investigator-chosen standard chemotherapy in patients with esophageal squamous cell carcinoma, according to data from a phase 3 study presented at the ASCO 2021 Annual Meeting. About TislelizumabTislelizumab (BGB-A317) is a type of precision ...
  • Elranatamab in Multiple Myeloma
    Will bispecific antibodies change the treatment of myeloma?
  • Mirvetuximab Soravtansine
    The Antibody Drug Conjugate Mirvetuximab soravtansine appears promising for treatment of certain patients with ovarian cancer.
  • Alrizomadlin
    Can resistance to immunotherapy be overcome with alrizomadlin?
  • Pimitespib Treatment for GIST
    Novel heat shock protein inhibitor Pimitespib promising for GIST
  • Afami-cel Elicits Durable Response Rates in Patients with Sarcoma
    Novel TCR immunotherapy promising for synovial sarcoma
  • Rusfertide-a New Option to Avoid Phlebotomy?
    Can PV patients avoid phlebotomy?
OncoTAb logo

NEWSLETTER

SOCIAL MEDIA

LINKS

AreYouDense.org
UnderstandBreastDensity.org

ADDRESS

243 Bioinformatics Bldg
9201 University City Blvd
Charlotte, NC 28223

PHONE

1-855-ONCOTAB (855-662-6822)

EMAIL

customerservice@oncotab.com

© 2019 COPYRIGHT OncoTAb, Inc. ALL RIGHTS RESERVED.

PRIVACY POLICY | TERMS OF USE

Not available for purchase by residents of CA, FL, MD, PA and NY.

Not available for purchase by residents of CA, NY, NJ, RI and MA.